Domov › Imunitný systém a poruchy › Kalifornia
Klinické štúdie Imunitný systém a poruchy v štáte Kalifornia
18 štúdií pre Imunitný systém a poruchy hľadá účastníkov v zariadeniach v štáte Kalifornia.
Mestá v štáte Kalifornia
Oficiálny text štúdie (anglicky)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07192471A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Chula Vista
Prebieha náborFáza 2
Vek 18 až 60 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07541287A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT06722235Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- PCR Oncology, Arroyo Grande
- Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
- Washington Health, Fremont
- a 3 ďalších
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT04242095(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT04996875A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06948318A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Northridge Clinical Trials, Northridge
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07765888A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- City of Hope, Duarte
- Stanford University, Palo Alto
- UCSF, San Francisco
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07075185Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of California-Irvine Medical Center, Irvine
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
- a 1 ďalších
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT05826535A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
Prebieha náborFáza 2
Vek 18 až 74 · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT07037901Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07216443Atacicept in Multiple Glomerular Diseases
- Vera Therapeutics, Brisbane
Prebieha náborFáza 2
Vek 2 a viac · Všetky pohlavia · Aktualizované 26. 6. 2026 · NCT06983028A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
- University of California, San Francisco, San Francisco
Prebieha náborFáza 2
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 6. 2026 · NCT05787574A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Stanford University, Dept. of Dermatology, Redwood City
- UC Davis, Dept. of Dermatology, Sacramento
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 5. 2026 · NCT04422912CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- City of Hope, Duarte
- Providence St. John's Health Center, Santa Monica
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 4. 2026 · NCT03328078Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
- USC / Norris Comprehensive Cancer Center, Los Angeles
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 a viac · Všetky pohlavia · Aktualizované 2. 4. 2026 · NCT03207854A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- City of Hope National Medical Center, Duarte
- Ronald Regan UCLA Medical Center, Los Angeles
- University of California Irvine Health, Orange
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 12. 2025 · NCT06619561Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 4. 2022 · NCT04684602Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.